Zevra Therapeutics, Inc.
ZVRA
$11.05
$0.252.32%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
Globe Newswire
5/12/2026
-
Tickeron - Stocks
5/11/2026
-
MarketBeat
5/11/2026
-
MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Zevra Therapeutics (ZVRA), CG Oncology, Inc. (CGON)
5/8/2026
-
TipRanks Financial Blog
5/8/2026
-
Simply Wall St
5/8/2026
-
MarketBeat
5/7/2026
-
TipRanks Financial Blog
5/7/2026
-
TipRanks Financial Blog
5/7/2026
-
Insider Monkey
5/7/2026
-
Seeking Alpha: Transcripts
5/7/2026
-
SeekingAlpha
5/7/2026
-
Simply Wall St
5/6/2026
-
Zacks Investment Research
5/6/2026
-
Zacks Investment Research
5/6/2026
-
The Cerbat Gem
5/6/2026
-
Seeking Alpha - Healthcare
5/6/2026
-
Globe Newswire
5/5/2026
-
Zacks Investment Research
5/5/2026
-
Zacks Investment Research
5/2/2026
-
Tickeron - Stocks
4/30/2026
-
Tickeron - Stocks
4/29/2026
-
MarketBeat
4/29/2026
-
Tickeron - Stocks
4/29/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 6, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
888 958 1253
Address
101 Federal Street
Boston, MA 02110
Boston, MA 02110
Country
Year Founded
Business Description
Sector
Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand...
more